The Mexican consensus on nonalcoholic fatty liver disease

被引：40

作者：

Bernal-Reyes, R. ^{[1
]}

Castro-Narro, G. ^{[2
]}

Male-Velazquez, R. ^{[3
]}

Carmona-Sanchez, R. ^{[4
]}

Gonzalez-Huezo, M. S. ^{[5
]}

Garcia-Juarez, I. ^{[2
]}

Chavez-Tapia, N. ^{[6
]}

Aguilar-Salinas, C. ^{[7
]}

Aiza-Haddad, I. ^{[8
]}

Ballesteros-Amozurrutia, M. A. ^{[9
]}

Bosques-Padilla, F. ^{[10
]}

Castillo-Barradas, M. ^{[11
]}

Chavez-Barrera, J. A. ^{[12
]}

Cisneros-Garza, L. ^{[13
]}

Flores-Calderon, J. ^{[14
]}

Garcia-Compean, D. ^{[13
]}

Gutierrez-Grobe, Y. ^{[6
]}

Higuera de la Tijera, M. F. ^{[15
]}

Kershenobich-Stalnikowitz, D. ^{[7
]}

Ladron de Guevara-Cetina, L. ^{[16
]}

Lizardi-Cervera, J. ^{[6
]}

Lopez-Cossio, J. A. ^{[5
]}

Martinez-Vazquez, S. ^{[2
]}

Marquez-Guillen, E. ^{[7
]}

Mendez-Sanchez, N. ^{[6
]}

Moreno-Alcantar, R. ^{[17
]}

Poo-Ramirez, J. L. ^{[18
]}

Ramos-Martinez, P. ^{[19
]}

Rodriguez-Hernandez, H. ^{[20
]}

Sanchez-Avila, J. F. ^{[21
]}

Stoopen-Rometti, M. ^{[22
]}

Torre-Delgadillo, A. ^{[2
]}

Torres-Villalobos, G. ^{[7
]}

Trejo-Estrada, R. ^{[23
]}

Uribe-Esquivel, M. ^{[6
]}

Velarde-Ruiz Valazco, J. A. ^{[24
]}

机构：

[1] Soc Espanola Beneficencia, Pachuca, Hidalgo, Mexico

[2] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Gastroenterol, Mexico City, DF, Mexico

[3] Inst Salud Digest & Hepat SA CV, Guadalajara, Jalisco, Mexico

[4] Consulta Privada, San Luis Potosi, Mexico

[5] ISSSEMYM, Serv Gastroenterol & Endoscopia GI, Metepec, Estado De Mexic, Mexico

[6] Fdn Clin Med Sur, Serv Gastroenterol, Mexico City, DF, Mexico

[7] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Mexico City, DF, Mexico

[8] Hosp Angeles Lomas, Clin Enfermedades Hepat, Mexico City, DF, Mexico

[9] Hosp Angeles Pedregal, Mexico City, DF, Mexico

[10] Ctr Med Zambrano Hell, Monterrey, Nuevo Leon, Mexico

[11] Hosp Especialidades Ctr Med La Raza, Ctr Med La Raza IMSS, Serv Gastroenterol, Mexico City, DF, Mexico

[12] IMSS, Ctr Med La Raza, Serv Gastroenterol Pediat, Hosp Gen, Mexico City, DF, Mexico

[13] Hosp Univ UANL, Serv Gastroenterol, Monterrey, Nuevo Leon, Mexico

[14] IMSS, Ctr Med Siglo 21, Hosp Pediat, Serv Gastroenterol, Mexico City, DF, Mexico

[15] Hosp Gen Mexico City, Serv Gastroenterol, Mexico City, DF, Mexico

[16] Hosp Angeles Clin Londres, Mexico City, DF, Mexico

[17] Hosp Especialidades Ctr Med La Raza, Ctr Med Siglo 21, IMSS, Serv Gastroenterol, Mexico City, DF, Mexico

[18] Tec Monterrey, Ctr Innovac & Educ Ejecut, Mexico City, DF, Mexico

[19] Ctr Patol Especializada SLP, San Luis Potosi, Mexico

[20] Hosp Especialidades Ctr Med La Raza, United Invest Biomed AMCCI, Durango, Mexico

[21] Tecnol Monterrey, Escuela Med & Ciencias Salud, Monterrey, Nuevo Leon, Mexico

[22] Ctr Diagnost CT Scanner Lomas Altas, Mexico City, DF, Mexico

[23] Ctr Med ABC, Mexico City, DF, Mexico

[24] Hosp Civil Guadalajara, Dept Gastroenterol, Guadalajara, Jalisco, Mexico

来源：

REVISTA DE GASTROENTEROLOGIA DE MEXICO | 2019年 / 84卷 / 01期

关键词：

Nonalcoholic fatty liver disease; Mexican consensus; CONTROLLED TRANSIENT ELASTOGRAPHY; INTRAHEPATIC LIPID-CONTENT; PLACEBO-CONTROLLED TRIAL; MAGNETIC-RESONANCE ELASTOGRAPHY; HEPATOCELLULAR-CARCINOMA HCC; DE-NOVO LIPOGENESIS; LONG-TERM OUTCOMES; VITAMIN-E; CRYPTOGENIC CIRRHOSIS; INSULIN-RESISTANCE;

D O I：

10.1016/j.rgmx.2018.11.007

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Nonalcoholic fatty liver disease (NAFLD) affects nearly one third of the population worldwide. Mexico is one of the countries whose population has several risk factors for the disease and its prevalence could surpass 50%. If immediate action is not taken to counteract what is now considered a national health problem, the medium-term panorama will be very bleak. This serious situation prompted the Asociacion Mexicana de Gastroenterologia and the Asociacion Mexicana de Hepatologia to produce the Mexican Consensus on Fatty Liver Disease. It is an up-to-date and detailed review of the epidemiology, pathaphysialogy, clinical forms, diagnosis, and treatment of the disease, whose aim is to provide the Mexican physician with a useful tool for the prevention and management of nonalcoholic fatty Liver disease. (C) 2019 Asociacion Mexicana de Gastroenterologia. Published by Masson Doyma Mexico S.A.

引用

页码：69 / 99

页数：31

共 50 条

[11] Nonalcoholic fatty liver disease
Brunt, Elizabeth M.
Wong, Vincent W. -S.
Nobili, Valerio
Day, Christopher P.
Sookoian, Silvia
Maher, Jacquelyn J.
Bugianesi, Elisabetta
Sirlin, Claude B.
Neuschwander-Tetri, BrentA.
Rinella, Mary E.
NATURE REVIEWS DISEASE PRIMERS, 2015, 1
[12] Nonalcoholic Fatty Liver Disease
Filipovic, Branka
Forbes, Alastair
Tepes, Bojan
Dumitrascu, Dan L.
CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 2018
[13] Nonalcoholic fatty liver disease
Bebawi, Emmanuel
Takla, Mark
Leonard, Jennifer
CANADIAN MEDICAL ASSOCIATION JOURNAL, 2023, 195 (26) : E909 - E909
[14] Nonalcoholic fatty liver disease
Lemoine, Maud
Serfaty, Lawrence
PRESSE MEDICALE, 2012, 41 (02): : 169 - 189
[15] Nonalcoholic Fatty Liver Disease
Worm, N.
Stein, J.
Strohle, A.
DIABETES STOFFWECHSEL UND HERZ, 2016, 25 (02): : 85 - 94
[16] Nonalcoholic fatty liver disease
Mach, Tomasz
PRZEGLAD GASTROENTEROLOGICZNY, 2007, 2 (02): : 101 - 105
[17] Nonalcoholic Fatty Liver Disease
Isaacs, Scott
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2023, 52 (01) : 149 - 164
[18] Nonalcoholic Fatty Liver Disease
Xia, Mao-Li
Wang, Hai
NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (03): : 294 - 295
[19] Nonalcoholic Fatty Liver Disease
Paredes, Angelo H.
Torres, Dawn M.
Harrison, Stephen A.
CLINICS IN LIVER DISEASE, 2012, 16 (02) : 397 - +
[20] Nonalcoholic fatty liver disease
Lall, Chandana G.
Aisen, Alex M.
Bansal, Navin
Sandrasegaran, Kumaresan
AMERICAN JOURNAL OF ROENTGENOLOGY, 2008, 190 (04) : 993 - 1002

← 1 2 3 4 5 →